NCT02832401View on ClinicalTrials.gov

The Impact of Caffeine on Cognition in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 2, 2016

Primary Completion Date

August 2, 2018

Study Completion Date

August 2, 2019

Conditions
SchizophreniaCaffeine
Interventions
DRUG

Caffeine

DRUG

Placebo

Trial Locations (1)

Unknown

BIOTIC Neuroimaging Laboratory, Halifax

All Listed Sponsors
collaborator

Dalhousie University

OTHER

collaborator

Mount Saint Vincent University

OTHER

lead

Nova Scotia Health Authority

OTHER

NCT02832401 - The Impact of Caffeine on Cognition in Schizophrenia | Biotech Hunter | Biotech Hunter